All Posts

When will smid-cap biopharma (e.g., XBI) stock prices start to increase again? Maybe when the biggest drivers for the downturn end or even reverse? So what are these 2 major drivers? US Federal Reserve interest rate increases U.S. Congress threats/action re: drug price controls/reform Here’s some background on the downturn, to help us understand why we think especially item 1, and to a lesser degree, item 2 are the main drivers. It’s been tough since 2021 for biotech investor

See our post "Two Strategies to Make Money in a Biopharma Down Market" for key strategies to make money regardless of whether XBI is in an upward or downward trend

At BPIQ, our goal is to help you make money investing in smid-cap biopharma stocks

In honor of the Obesity week conference, which starts tomorrow:

In honor of the Obesity week conference, which starts tomorrow: How can investors profit from weight loss drug (e.g. Wegovy) breakthroughs? Invest in companies that currently lead in this space Invest in companies developing new drugs in this space Large caps Smid-caps Leading type-2 diabetes (T2D)/weight loss drugs are GLP-1 agonists, GIP agonists, Amylin analogues,& SGLT-2s We will focus on GLP-1s for this post The GLP-1 market was $22B in '22 & projected to reach >$50B by

What is a Big-Mover™ event? Big-Mover™ events are upcoming high-impact biopharma catalyst events, usually clinical trial read-outs, that are expected to move a stock by at least 20% up or down. Big Mover™ events are typically a type of event with the highest chance of moving a stock (e.g. Phase 2, Phase 3, and PDUFA read-outs) given the importance of the clinical asset to the sponsor company. We call clinical events that appear likely to be Big Mover events Suspected Big Move

How can hedge fund data help biotech investors? Hedge fund holdings can help you discover new investment ideas and get more conviction about your current holdings. For example, you can see how many top biotech or biopharma hedge funds hold your favorite companies or which tickers are the most popular tickers amongst top biotech or biopharma hedge funds. When you use hedge fund information, you leverage the expertise and resources of top hedge funds for your investment decisio

What biotech M&A data does BPIQ offer? Free: M&A Activity History Pro: M&A Activity History Elite: M&A Activity History M&A Our and Othe Picks Amp: M&A Activity History M&A Our and Othe Picks *See pictures below for visuals M&A Activity History: M&A Our and Othe Picks This article is NOT legal, investment or tax advice. Please do your own diligence before making any investment decisions.

What are Biotech Catalyst Events? Biotech catalyst events are significant milestones in the biopharmaceutical industry that can trigger substantial changes in stock prices. These events include clinical trial results, regulatory decisions, data presentations, and other developments that can impact the future prospects of biotech companies. Why are Biotech Catalyst Events Important for Retail Investors? Biotech catalyst events have a direct influence on the value of biotech st

What is a PDUFA Date? A Prescription Drug User Fee Act (PDUFA) date is a pivotal milestone for pharmaceutical companies. It marks the FDA's expected completion date for reviewing New Drug Applications (NDAs) and Biologics License Applications (BLAs) submitted by companies seeking approval for new drugs. PDUFA dates are essential for planning marketing strategies, informing investors, and anticipating the potential approval of a new treatment. Why are PDUFA Dates Important for